VANDA PHARMACEUTICALS INC
VNDA · NASDAQ
Updated at 2026-10-14 09:06:44
- Today's High
- $4.54
- Today’s Low
- $4.28
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.56
- Previous Close
- $4.54
- Volume
- 519.67K
- Market Cap
- $274.5M
- P/E Ratio
- --
- EPS
- $-4.62
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 2200 PENNSYLVANIA AVENUE NW, WASHINGTON, DC, UNITED STATES, 20037
- Country
- US
- Listing Date
- 2006-04-12
- Fiscal Year End
- December
- Shares Outstanding
- 60.14M
- CIK
- 0001347178
- Website
- www.vandapharma.com
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia.
Financial Metrics
Revenue
2026-06-30
$50.52M
2026-03-31
$51.71M
2025-12-31
$57.21M
2025-09-30
$56.25M
Operating Expenses
2026-06-30
$110.77M
2026-03-31
$96.79M
2025-12-31
$93.73M
2025-09-30
$84.58M
Net Income
2026-06-30
-$62.51M
2026-03-31
-$48.56M
2025-12-31
-$141.18M
2025-09-30
-$22.58M
Net Profit Margin
2026-06-30
-123.71%
2026-03-31
-93.9%
2025-12-31
-246.76%
2025-09-30
-40.14%
Earnings Per Share
2026-06-30
$-1.04
2026-03-31
$-0.82
2025-12-31
$-2.39
2025-09-30
$-0.38
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$61.52M
2026-03-31
-$44.89M
2025-12-31
-$32.13M
2025-09-30
-$26.33M
Effective Tax Rate
2026-06-30
-0.2%
2026-03-31
-0.29%
2025-12-31
-271.52%
2025-09-30
20.44%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $50.52M | $51.71M | $57.21M | $56.25M |
| Operating Expenses | $110.77M | $96.79M | $93.73M | $84.58M |
| Net Income | -$62.51M | -$48.56M | -$141.18M | -$22.58M |
| Net Profit Margin | -123.71% | -93.9% | -246.76% | -40.14% |
| Earnings Per Share | $-1.04 | $-0.82 | $-2.39 | $-0.38 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$61.52M | -$44.89M | -$32.13M | -$26.33M |
| Effective Tax Rate | -0.2% | -0.29% | -271.52% | 20.44% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.